How is insulin made by genetically modified bacteria used in medicine?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Insulin produced by genetically modified bacteria is a cornerstone of modern diabetes mellitus treatment. By using recombinant DNA technology, scientists insert the human gene sequence for insulin into laboratory strains of bacteria, such as Escherichia coli. These bacteria act as biological factories, synthesizing human insulin that is identical to the hormone naturally produced in the body.12

This method replaced earlier practices of extracting insulin from the pancreases of cows and pigs, which carried risks and supply limitations. The synthetic version offers improved purity, safety, and availability.32

In clinical practice, this insulin is used to mimic the body's natural secretion patterns:4
* Short-acting insulin: Acts quickly but transiently to manage blood glucose levels.4
* Long-acting insulin: Biochemically modified to provide a steady, low level of insulin for up to 24 hours.4
* Rapid-acting insulin: Designed to lower blood glucose within 10 to 30 minutes of administration.4

Patients typically administer these preparations via injections or insulin pumps to maintain metabolic balance.4